Section Arrow
INVA.NASDAQ
- Innoviva
Quotes are at least 15-min delayed:2026/07/07 14:16 EDT
Regular Hours
Last
 22.12
+0.3 (+1.37%)
Day High 
22.37 
Prev. Close
21.82 
1-M High
24.17 
Volume 
218.70K 
Bid
22.11
Ask
22.13
Day Low
21.9 
Open
22.11 
1-M Low
21.7 
Market Cap 
1.65B 
Currency 美元 
P/E 3.49 
%Yield 1.13 
10-SMA 22.87 
20-SMA 22.72 
50-SMA 22.6 
52-W High 25.145 
52-W Low 16.52 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
6.26/2.36
Enterprise Value
1.92B
Balance Sheet
Book Value Per Share
18.18
Cash Flow
Cash Flow Yield
0.09
Income Statement
Total Revenue
411.33M
Operating Revenue Per Share
3.93
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CRNXCrinetics Pharmaceuticals83.5+41.47+98.67%-- 
TVRDTvardi Therapeutics Inc2.99+0.98+48.76%-- 
RXRXRecursion Pharmaceuticals3.92-0.04-1.01%-- 
TOVXTheriva Biologics Inc0.23165-0.02165-8.55%-- 
VANIVivani Medical1.335+0.035+2.69%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its productoffering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.